SK15222003A3 - Amidy kyseliny antranilovej s heteroarylsulfonylovým postranným reťazcom, ich použitie ako liečiv alebo diagnostík a farmaceutické prostriedky s ich obsahom - Google Patents

Amidy kyseliny antranilovej s heteroarylsulfonylovým postranným reťazcom, ich použitie ako liečiv alebo diagnostík a farmaceutické prostriedky s ich obsahom Download PDF

Info

Publication number: SK15222003A3
Authority: SK; Slovakia
Prior art keywords: group; groups; carbon atoms; atoms; alkyl
Prior art date: 2001-06-12

Application number

SK1522-2003A

Other languages

English (en)

Slovak (sk)

Inventor

Joachim Brendel

Thomas B�Hme

Stefan Peukert

Heinz-Werner Kleemann

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-12

Filing date

2002-05-31

Publication date

2004-06-08

2002-05-31 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2004-06-08 Publication of SK15222003A3 publication Critical patent/SK15222003A3/sk

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Pyridine Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

SK1522-2003A 2001-06-12 2002-05-31 Amidy kyseliny antranilovej s heteroarylsulfonylovým postranným reťazcom, ich použitie ako liečiv alebo diagnostík a farmaceutické prostriedky s ich obsahom SK15222003A3 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10128331A DE10128331A1 (de)	2001-06-12	2001-06-12	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
PCT/EP2002/005956 WO2002100825A2 (de)	2001-06-12	2002-05-31	Anthranilsäureamide mit heteroarylsulfonyl-seitenkette und ihre verwendung als antiarrhythmische wirkstoffe

Publications (1)

Publication Number	Publication Date
SK15222003A3 true SK15222003A3 (sk)	2004-06-08

Family

ID=7687941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1522-2003A SK15222003A3 (sk)	2001-06-12	2002-05-31	Amidy kyseliny antranilovej s heteroarylsulfonylovým postranným reťazcom, ich použitie ako liečiv alebo diagnostík a farmaceutické prostriedky s ich obsahom

Country Status (41)

Country	Link
US (2)	US6903216B2 (zh)
EP (1)	EP1399423B9 (zh)
JP (1)	JP4422477B2 (zh)
KR (1)	KR100863924B1 (zh)
CN (1)	CN1247544C (zh)
AR (1)	AR036045A1 (zh)
AT (1)	ATE378318T1 (zh)
AU (1)	AU2002316939B2 (zh)
BG (1)	BG108415A (zh)
BR (1)	BR0210374A (zh)
CA (1)	CA2450076C (zh)
CO (1)	CO5540283A2 (zh)
CR (1)	CR7140A (zh)
CY (1)	CY1107427T1 (zh)
CZ (1)	CZ20033361A3 (zh)
DE (2)	DE10128331A1 (zh)
DK (1)	DK1399423T3 (zh)
EC (1)	ECSP034883A (zh)
EE (1)	EE05196B1 (zh)
ES (1)	ES2295360T3 (zh)
HK (1)	HK1065316A1 (zh)
HR (1)	HRP20031028A2 (zh)
HU (1)	HUP0400159A3 (zh)
IL (2)	IL159247A0 (zh)
MA (1)	MA27037A1 (zh)
MX (1)	MXPA03010875A (zh)
MY (1)	MY138341A (zh)
NO (1)	NO20035450D0 (zh)
NZ (1)	NZ530081A (zh)
OA (1)	OA12631A (zh)
PE (1)	PE20021066A1 (zh)
PL (1)	PL364371A1 (zh)
PT (1)	PT1399423E (zh)
RS (1)	RS97703A (zh)
RU (1)	RU2293727C2 (zh)
SK (1)	SK15222003A3 (zh)
TN (1)	TNSN03134A1 (zh)
TW (1)	TWI304400B (zh)
UA (1)	UA75412C2 (zh)
WO (1)	WO2002100825A2 (zh)
ZA (1)	ZA200308520B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
US7119112B2 (en) *	2002-02-28	2006-10-10	Icagen, Inc.	Sulfonamides as potassium channel blockers
EP1500650A4 (en) *	2002-04-26	2006-08-23	Ishihara Sangyo Kaisha	PYRIDINE COMPOUNDS OR SALTS THEREOF AND HERBICIDES CONTAINING SAME
EP1388535A1 (en) *	2002-08-07	2004-02-11	Aventis Pharma Deutschland GmbH	Acylated arylcycloalkylamines and their use as pharmaceuticals
DE10312061A1 (de) *	2003-03-18	2004-09-30	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit Blockern des IK-Kanals und deren Verwendung zur Behandlung von Vorhofarrhythmien
GB0315950D0 (en)	2003-06-11	2003-08-13	Xention Discovery Ltd	Compounds
EP1489071A1 (en) *	2003-06-18	2004-12-22	4Sc Ag	N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators
WO2005016896A1 (en)	2003-08-08	2005-02-24	Janssen Pharmaceutica, N.V.	2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators
DE10341233A1 (de) *	2003-09-08	2005-03-24	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
DE102004009931A1 (de) *	2004-02-26	2005-09-15	Aventis Pharma Deutschland Gmbh	Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
GB0412986D0 (en)	2004-06-10	2004-07-14	Xention Discovery Ltd	Compounds
US7569589B2 (en)	2004-07-29	2009-08-04	Merck & Co., Inc.	Potassium channel inhibitors
KR20070057252A (ko)	2004-09-24	2007-06-04	얀센 파마슈티카 엔.브이.	설폰아미드 화합물
US7576212B2 (en)	2004-12-09	2009-08-18	Xention Limited	Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0525164D0 (en)	2005-12-09	2006-01-18	Xention Discovery Ltd	Compounds
KR101390239B1 (ko) *	2006-04-27	2014-04-30	사노피-아벤티스 도이칠란트 게엠베하	Ｔａｓｋ-1 및 ｔａｓｋ-3 이온 채널 억제제
WO2008124524A2 (en) *	2007-04-03	2008-10-16	Janssen Pharmaceutica N.V.	Aryl sulfonamide compounds as modulators of the cck2 receptor
GB0815782D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815781D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815784D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
PL2448909T3 (pl) *	2009-06-29	2013-09-30	Merz Pharma Gmbh & Co Kgaa	Sposób wytwarzania 1-amino-1,3,3,5,5-pentametylocykloheksanu
AR077292A1 (es)	2009-06-29	2011-08-17	Agios Pharmaceuticals Inc	Derivados de piperazin - quinolin sulfonamidas y composiciones farmaceuticas
WO2011010132A1 (en) *	2009-07-21	2011-01-27	Astrazeneca Ab	Sustained-release composition comprising compound 600
FR2967674B1 (fr) *	2010-11-23	2012-12-14	Pf Medicament	Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
GB201105659D0 (en)	2011-04-01	2011-05-18	Xention Ltd	Compounds
NO3175985T3 (zh)	2011-07-01	2018-04-28
JP2015504923A (ja)	2012-01-27	2015-02-16	ギリアードサイエンシーズ，インコーポレイテッド	後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法
US9701627B2 (en) *	2014-06-16	2017-07-11	University Of Maryland, Baltimore	LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
CN111183129B (zh) *	2017-08-07	2024-07-23	国立大学法人广岛大学	新型邻氨基苯甲酸系化合物、使用了该化合物的Pin1抑制剂、炎症性疾病及癌症的治疗剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2128644C1 (ru)	1993-12-27	1999-04-10	Эйсай Ко., Лтд.	Производные антраниловой кислоты или их фармакологически приемлемые соли, промежуточные продукты для их получения и лекарственный препарат на их основе
US5670504A (en)	1995-02-23	1997-09-23	Merck & Co. Inc.	2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en)	1996-07-26	2000-07-04	Icagen, Inc.	Potassium channel inhibitors
DK173062B1 (da)	1996-10-11	1999-12-13	Krueger As I	Fremgangsmåde til fjernelse af opløste metaller og/eller metalloider fra et vandigt medium indeholdende samme og med et sto
US5935945A (en)	1996-10-31	1999-08-10	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
US5969017A (en)	1996-10-31	1999-10-19	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
ATE309206T1 (de)	1998-07-08	2005-11-15	Sanofi Aventis Deutschland	Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
WO2000012077A1 (en)	1998-09-01	2000-03-09	Bristol-Myers Squibb Company	Potassium channel inhibitors and method
WO2000078145A1 (en) *	1999-06-24	2000-12-28	Smithkline Beecham Corporation	Macrophage scavenger receptor antagonists
DE19947457A1 (de) *	1999-10-02	2001-04-05	Aventis Pharma Gmbh	2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en)	1999-10-02	2003-03-11	Aventis Pharma Deutschland Gmbh	2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

2001
- 2001-06-12 DE DE10128331A patent/DE10128331A1/de not_active Withdrawn
2002
- 2002-05-17 PE PE2002000419A patent/PE20021066A1/es not_active Application Discontinuation
- 2002-05-21 OA OA1200300333A patent/OA12631A/fr unknown
- 2002-05-31 HU HU0400159A patent/HUP0400159A3/hu unknown
- 2002-05-31 PL PL02364371A patent/PL364371A1/xx not_active IP Right Cessation
- 2002-05-31 DK DK02745333T patent/DK1399423T3/da active
- 2002-05-31 UA UA2004010206A patent/UA75412C2/uk unknown
- 2002-05-31 RS YU97703A patent/RS97703A/sr unknown
- 2002-05-31 BR BR0210374-5A patent/BR0210374A/pt not_active Application Discontinuation
- 2002-05-31 EE EEP200300558A patent/EE05196B1/xx not_active IP Right Cessation
- 2002-05-31 DE DE50211213T patent/DE50211213D1/de not_active Expired - Lifetime
- 2002-05-31 AT AT02745333T patent/ATE378318T1/de active
- 2002-05-31 CZ CZ20033361A patent/CZ20033361A3/cs unknown
- 2002-05-31 SK SK1522-2003A patent/SK15222003A3/sk unknown
- 2002-05-31 EP EP02745333A patent/EP1399423B9/de not_active Expired - Lifetime
- 2002-05-31 WO PCT/EP2002/005956 patent/WO2002100825A2/de active IP Right Grant
- 2002-05-31 MX MXPA03010875A patent/MXPA03010875A/es active IP Right Grant
- 2002-05-31 CA CA2450076A patent/CA2450076C/en not_active Expired - Fee Related
- 2002-05-31 PT PT02745333T patent/PT1399423E/pt unknown
- 2002-05-31 JP JP2003503594A patent/JP4422477B2/ja not_active Expired - Fee Related
- 2002-05-31 ES ES02745333T patent/ES2295360T3/es not_active Expired - Lifetime
- 2002-05-31 IL IL15924702A patent/IL159247A0/xx unknown
- 2002-05-31 NZ NZ530081A patent/NZ530081A/en unknown
- 2002-05-31 RU RU2004100302/04A patent/RU2293727C2/ru not_active IP Right Cessation
- 2002-05-31 CN CNB028118502A patent/CN1247544C/zh not_active Expired - Fee Related
- 2002-05-31 AU AU2002316939A patent/AU2002316939B2/en not_active Ceased
- 2002-05-31 KR KR1020037016206A patent/KR100863924B1/ko not_active IP Right Cessation
- 2002-06-10 TW TW091112464A patent/TWI304400B/zh not_active IP Right Cessation
- 2002-06-10 AR ARP020102178A patent/AR036045A1/es active IP Right Grant
- 2002-06-11 MY MYPI20022165A patent/MY138341A/en unknown
- 2002-06-12 US US10/166,595 patent/US6903216B2/en not_active Expired - Lifetime
2003
- 2003-07-08 TN TNPCT/EP2002/005956A patent/TNSN03134A1/en unknown
- 2003-10-31 ZA ZA200308520A patent/ZA200308520B/en unknown
- 2003-11-04 CR CR7140A patent/CR7140A/es not_active Application Discontinuation
- 2003-12-03 EC EC2003004883A patent/ECSP034883A/es unknown
- 2003-12-04 BG BG108415A patent/BG108415A/xx unknown
- 2003-12-08 NO NO20035450A patent/NO20035450D0/no not_active Application Discontinuation
- 2003-12-08 IL IL159247A patent/IL159247A/en not_active IP Right Cessation
- 2003-12-10 MA MA27434A patent/MA27037A1/fr unknown
- 2003-12-11 HR HR20031028A patent/HRP20031028A2/hr not_active Application Discontinuation
- 2003-12-11 CO CO03108701A patent/CO5540283A2/es not_active Application Discontinuation
2004
- 2004-10-20 HK HK04108195A patent/HK1065316A1/xx not_active IP Right Cessation
2005
- 2005-02-08 US US11/052,959 patent/US7235664B2/en not_active Expired - Lifetime
2008
- 2008-02-04 CY CY20081100143T patent/CY1107427T1/el unknown

Also Published As

Publication number	Publication date
US6903216B2 (en)	2005-06-07
MXPA03010875A (es)	2004-02-17
TNSN03134A1 (en)	2005-12-23
WO2002100825A2 (de)	2002-12-19
EP1399423B1 (de)	2007-11-14
DE10128331A1 (de)	2002-12-19
EP1399423B9 (de)	2008-02-27
NZ530081A (en)	2005-07-29
CA2450076A1 (en)	2002-12-19
AR036045A1 (es)	2004-08-04
EE05196B1 (et)	2009-08-17
ES2295360T3 (es)	2008-04-16
US20030114499A1 (en)	2003-06-19
IL159247A0 (en)	2004-06-01
HUP0400159A2 (hu)	2004-07-28
CY1107427T1 (el)	2012-12-19
KR20040030668A (ko)	2004-04-09
HRP20031028A2 (en)	2005-10-31
CO5540283A2 (es)	2005-07-29
ZA200308520B (en)	2004-09-06
PE20021066A1 (es)	2003-01-21
DE50211213D1 (de)	2007-12-27
BR0210374A (pt)	2004-07-13
UA75412C2 (en)	2006-04-17
IL159247A (en)	2010-06-16
BG108415A (en)	2004-07-30
WO2002100825A3 (de)	2003-12-11
CN1529695A (zh)	2004-09-15
CN1247544C (zh)	2006-03-29
CR7140A (es)	2004-04-15
RS97703A (en)	2006-12-15
HK1065316A1 (en)	2005-02-18
TWI304400B (en)	2008-12-21
RU2004100302A (ru)	2005-04-10
KR100863924B1 (ko)	2008-10-17
HUP0400159A3 (en)	2008-10-28
JP2004533464A (ja)	2004-11-04
US7235664B2 (en)	2007-06-26
NO20035450D0 (no)	2003-12-08
AU2002316939B2 (en)	2006-11-23
PL364371A1 (en)	2004-12-13
ATE378318T1 (de)	2007-11-15
RU2293727C2 (ru)	2007-02-20
JP4422477B2 (ja)	2010-02-24
EP1399423A2 (de)	2004-03-24
CZ20033361A3 (cs)	2004-05-12
MA27037A1 (fr)	2004-12-20
CA2450076C (en)	2010-11-30
DK1399423T3 (da)	2008-03-17
EE200300558A (et)	2004-02-16
PT1399423E (pt)	2008-02-07
MY138341A (en)	2009-05-29
US20050137200A1 (en)	2005-06-23
OA12631A (fr)	2006-06-14
ECSP034883A (es)	2004-01-28

Legal Events

Date	Code	Title	Description
2010-12-07	FB9A	Suspension of patent application procedure

Publication	Publication Date	Title
SK15222003A3 (sk)	2004-06-08	Amidy kyseliny antranilovej s heteroarylsulfonylovým postranným reťazcom, ich použitie ako liečiv alebo diagnostík a farmaceutické prostriedky s ich obsahom
RU2283833C2 (ru)	2006-09-20	Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции
JP4713800B2 (ja)	2011-06-29	２′−置換１，１′−ビフェニル−２−カルボキサミド、その製造、医薬としてのその使用およびそれを含む医薬組成物
LV12258B (en)	1999-09-20	DIAMINOCYCLOBUTE-3,4-DIONES AS GLUDO MUSCULAR RELAXATION
SK6532003A3 (en)	2003-12-02	Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
WO2011145669A1 (ja)	2011-11-24	アミド誘導体
WO2004083204A1 (en)	2004-09-30	6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists
SK17698A3 (en)	1998-09-09	Sulfonamide substituted compounds, a medicament containing same and their use
MXPA98001121A (en)	1998-11-12	Compositions replaced with sulfonamide, procedure for its preparation, its employment as a diagnostic medicine or agent as well as a medicine that conti
JPH06211770A (ja)	1994-08-02	シアノアミジン誘導体